(Q53120189)

11 May 2018

title

How to manage antiplatelet therapy for stenting in a patient requiring oral anticoagulants. (English)

1 reference

11 May 2018

1 reference

1 reference

David P Faxon

1

1 reference

11 May 2018

publication date

1 February 2013

1 reference

11 May 2018

Current treatment options in cardiovascular medicine

published in

1 reference

11 May 2018

volume

15

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

11-20

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s11936-012-0222-5

exact match

0 references

cites work

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Very late stent thrombosis and late target lesion revascularization: no end in sight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

A risk score to predict bleeding in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0222-5

A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)

21 January 2018

1 reference

12 December 2020

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

1 reference

12 December 2020

Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes

1 reference

12 December 2020

Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S11936-012-0222-5

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018